Intravenous adenosine reduces myocardial no-reflow by decreasing endothelin-1 via activation of the ATP-sensitive K+ channel.

Zhao, Jing-Lin

Intravenous adenosine reduces myocardial no-reflow by decreasing endothelin-1 via activation of the ATP-sensitive K+ channel. [electronic resource] - Acta cardiologica Jun 2008 - 355-9 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

0001-5385

10.2143/AC.63.3.1020313 doi


Adenosine--administration & dosage
Animals
Coronary Circulation--drug effects
Disease Models, Animal
Echocardiography
Endothelin-1--blood
Injections, Intravenous
KATP Channels--drug effects
Myocardial Infarction--diagnosis
Myocardial Reperfusion Injury--diagnosis
Myocardium--metabolism
Radioimmunoassay
Random Allocation
Swine
Swine, Miniature
Treatment Outcome
Vasodilator Agents--administration & dosage